Status:
UNKNOWN
Validation of the VascuQoL-6 Questionnaire to Assess ePROM After Revascularization for Lower Limb Peripheral Arterial Disease in German-speaking Part of Switzerland
Lead Sponsor:
Kantonsspital Aarau
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
18+ years
Brief Summary
Two hundred patients evaluated to undergo revascularization (elective/emergent, surgical/interventional) for lower limb PAD at the cantonal hospital of Aarau, Switzerland, will, after consenting to pa...
Detailed Description
Lower extremity peripheral artery disease is a chronic illness that has a significant effect on the quality of life of the patients in short- as well as long-term. Generic Instruments, such as widely...
Eligibility Criteria
Inclusion
- confirmed PAD
- elective or emergent revascularization indicated (surgery/intervention)
- native German speakers - no cognitive impairment
Exclusion
- not fulfilling any of the inclusion criteria
- patients refusing to participate
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04709107
Start Date
March 1 2021
End Date
December 31 2023
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonsspital Aarau
Aarau, Canton of Aargau, Switzerland, 5000